Sources sought
Request for Information (RFI) - Atropine and Pralidoxime Chloride Injection, single dose auto-injectors
SNS-RFI-4152024
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.
Response deadline
April 23, 2024 at 2:00 PM EDT
Closed 878 days ago. Posted April 15, 2024. Scheduled to archive May 8, 2024.
Description
As published on SAM.gov.
The Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) is seeking information on vendor’s availability to provide acceptable pharmaceuticals of Atropine and Pralidoxime Chloride Injection, single dose auto-injectors that delivers 2.1mg/0.7ml atropine and 600mg/2mg(300mg/ml) pralidoxime chloride. SNS requires that all pharmaceuticals are FDA approved.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 15, 2024
Sources sought
Due April 23, 2024 at 2:00 PM EDT. SAM.gov, notice 350bda45903f4a66a65e5a88127b3474
Points of contact
- LaMonica Norwoodlamonica.norwood@hhs.gov
Also open from this buyer
- SNS Pharmaceutical Logistic Replenishment RequirementCombined synopsis and solicitationNAICS 325412New York75A50326R00007Closes todaySep 18